rethinkTHC Search
Menu
Study breakdown

Cannabis use disorder was 68% more common in pediatric patients hospitalized for prescription opioid overdose

Retrospective CohortStrong evidence
The takeaway

Among 27 million pediatric inpatients, those hospitalized for prescription opioid overdose had 68% higher odds of comorbid cannabis use disorder, with mood disorders present in 44%.

Pediatricians, adolescent medicine specialists, and opioid prescribing clinicians.

Cannabis use disorder: 68% higher odds in pediatric opioid overdose cases

What the researchers found

In 27,444,239 pediatric hospitalizations (NIS database), 10,562 (0.04%) involved prescription opioid overdose. Cannabis use disorder was present in 14.2% of opioid overdose cases and was independently associated with higher hospitalization odds (OR 1.68, CI 1.57-1.81). Adolescents had 10.75 times higher odds than children under 12. Mood disorders (44.3%) and anxiety (14.6%) were the most common comorbidities.

Why it matters

Understanding which pediatric patients are at highest risk for opioid overdose helps target prevention. The cannabis-opioid association suggests overlapping vulnerability rather than a gateway effect.

The numbers in context

27.4M hospitalizations; 10,562 opioid overdoses (0.04%); cannabis use disorder OR 1.68; tobacco OR 1.58; opioid use disorder OR 8.79; 44.3% had mood disorders; adolescents OR 10.75 vs children.

How the study worked

Retrospective analysis of the Nationwide Inpatient Sample (NIS) with 27,444,239 pediatric hospitalizations, using logistic regression to assess associations between substance use disorders and prescription opioid overdose.

What this study cannot tell us

Administrative database (ICD codes may underidentify substance use); cross-sectional associations cannot establish temporal order; cannot distinguish recreational from prescription cannabis; database coding limitations for pediatric substance use.

How to read the evidence

Strong: massive national database with appropriate statistical adjustments.

When this study was published

Published 2020.

The bigger picture

The co-occurrence of cannabis, opioid, and mood disorders in pediatric overdose patients points to shared underlying vulnerability rather than one substance leading to another. This argues for integrated screening and treatment.

Questions still open

  • Does treating cannabis use disorder reduce opioid overdose risk in adolescents? Should cannabis screening be routine in pediatric patients prescribed opioids?

Common questions

Are cannabis-using teens more likely to overdose on opioids?
In this database study, cannabis use disorder was associated with 68% higher odds of prescription opioid overdose hospitalization. However, this likely reflects shared vulnerability rather than cannabis causing opioid use.
What was the most common co-occurring condition?
Mood disorders were present in 44.3% of pediatric opioid overdose cases, making mental health the largest comorbidity, followed by anxiety disorders (14.6%) and cannabis use disorder (14.2%).

Read the original research

Recreational Cannabis Use and Risk of Prescription Opioid Overdose: Insights from Pediatric Inpatients.

Cureus, 12(10), e11058

Citation

Pankaj, Amaya; Oraka, Kosisochukwu; Caraballo-Rivera, Emmanuelle J; Ahmad, Munazza; Zahid, Shaheer; Munir, Sadaf; Gurumurthy, Gayathri; Okoeguale, Onose; Verma, Shikha; Patel, Rikinkumar S. (2020). Recreational Cannabis Use and Risk of Prescription Opioid Overdose: Insights from Pediatric Inpatients.. Cureus, 12(10), e11058. https://doi.org/10.7759/cureus.11058

Explore the wider topic